AT295744B - Verfahren zur Herstellung markierter Antikörper gegen Reagin-Immunoglobuline - Google Patents
Verfahren zur Herstellung markierter Antikörper gegen Reagin-ImmunoglobulineInfo
- Publication number
- AT295744B AT295744B AT359370A AT359370A AT295744B AT 295744 B AT295744 B AT 295744B AT 359370 A AT359370 A AT 359370A AT 359370 A AT359370 A AT 359370A AT 295744 B AT295744 B AT 295744B
- Authority
- AT
- Austria
- Prior art keywords
- reagin
- immunoglobulins
- production
- antibodies against
- labeled antibodies
- Prior art date
Links
- RZZPDXZPRHQOCG-OJAKKHQRSA-O CDP-choline(1+) Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OCC[N+](C)(C)C)O[C@H]1N1C(=O)N=C(N)C=C1 RZZPDXZPRHQOCG-OJAKKHQRSA-O 0.000 title 1
- 108060003951 Immunoglobulin Proteins 0.000 title 1
- 102000018358 immunoglobulin Human genes 0.000 title 1
- 229940072221 immunoglobulins Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0058—Antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
- A61K49/0043—Fluorescein, used in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1015—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1018—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1078—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being against an immunoglobulin, i.e. being an (anti)-anti-idiotypic antibody
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
- C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Optics & Photonics (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Endocrinology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1229767A SE341239B (de) | 1967-09-06 | 1967-09-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT295744B true AT295744B (de) | 1972-01-10 |
Family
ID=20295495
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT359370A AT295744B (de) | 1967-09-06 | 1968-09-06 | Verfahren zur Herstellung markierter Antikörper gegen Reagin-Immunoglobuline |
| AT873168A AT288593B (de) | 1967-09-06 | 1968-09-06 | Verfahren zur Bestimmung von gegen bestimmte Allergene wirkenden Reagin-Immunoglobulinen (Reagin-Ig) in wässerigen Testproben |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT873168A AT288593B (de) | 1967-09-06 | 1968-09-06 | Verfahren zur Bestimmung von gegen bestimmte Allergene wirkenden Reagin-Immunoglobulinen (Reagin-Ig) in wässerigen Testproben |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JPS50892B1 (de) |
| AT (2) | AT295744B (de) |
| BE (1) | BE720341A (de) |
| CH (1) | CH534878A (de) |
| CS (1) | CS191857B2 (de) |
| DK (1) | DK131400B (de) |
| ES (1) | ES357863A1 (de) |
| FI (1) | FI48785C (de) |
| FR (1) | FR1588874A (de) |
| GB (1) | GB1248764A (de) |
| NL (1) | NL162209C (de) |
| NO (2) | NO127685B (de) |
| SE (1) | SE341239B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154600B (nl) * | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
| USRE31006E (en) * | 1968-09-24 | 1982-08-03 | Akzona Incorporated | Process for the demonstration and determination of reaction components having specific binding affinity for each other |
| US3966897A (en) * | 1973-04-02 | 1976-06-29 | Marine Colloids, Inc. | Medium for use in bioassay and method of using same |
| US4041146A (en) * | 1975-05-01 | 1977-08-09 | General Electric Company | Method for detection of biological particles |
| GB1555142A (en) * | 1975-08-14 | 1979-11-07 | Sinai School Medicine | Blood cell typing and compatibility test procedure |
| AT343822B (de) * | 1976-08-20 | 1978-06-26 | Immuno Ag | Radioimmunologisches verfahren und einrichtung zur bestimmung von antigenen |
| US4289748A (en) * | 1979-05-31 | 1981-09-15 | United States Of America | Ultrasensitive enzymatic radioimmunoassay method |
| FR2502786B1 (fr) * | 1981-03-24 | 1985-06-21 | Stallergenes Laboratoire | Procede de fixation d'antigenes et d'anticorps sur support de polysaccharides, et utilisation du produit ainsi obtenu pour les dosages immunologiques |
| US4481298A (en) * | 1981-04-13 | 1984-11-06 | Amf Incorporated | Pre-precipitated double antibody immunoassay method |
| NL8102178A (nl) * | 1981-05-02 | 1982-12-01 | Stichting Centraal Lab | Werkwijze voor het aantonen van tegen bepaalde antigenen gerichte antistoffen, alsmede inrichting en reagentia voor het uitvoeren van deze werkwijze. |
| JPS6199195U (de) * | 1984-11-30 | 1986-06-25 |
-
1967
- 1967-09-06 SE SE1229767A patent/SE341239B/xx unknown
-
1968
- 1968-08-28 FR FR1588874D patent/FR1588874A/fr not_active Expired
- 1968-08-30 DK DK418468A patent/DK131400B/da not_active IP Right Cessation
- 1968-09-02 CH CH1313868A patent/CH534878A/de not_active IP Right Cessation
- 1968-09-03 BE BE720341D patent/BE720341A/xx not_active IP Right Cessation
- 1968-09-03 GB GB4180168A patent/GB1248764A/en not_active Expired
- 1968-09-04 NL NL6812559A patent/NL162209C/xx not_active IP Right Cessation
- 1968-09-05 FI FI249868A patent/FI48785C/fi active
- 1968-09-05 NO NO345868A patent/NO127685B/no unknown
- 1968-09-06 AT AT359370A patent/AT295744B/de not_active IP Right Cessation
- 1968-09-06 JP JP6421968A patent/JPS50892B1/ja active Pending
- 1968-09-06 CS CS626568A patent/CS191857B2/cs unknown
- 1968-09-06 AT AT873168A patent/AT288593B/de not_active IP Right Cessation
-
1969
- 1969-09-05 ES ES357863A patent/ES357863A1/es not_active Expired
-
1972
- 1972-07-11 NO NO247772A patent/NO138182C/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO138182B (no) | 1978-04-10 |
| JPS50892B1 (de) | 1975-01-13 |
| DK131400B (da) | 1975-07-07 |
| NO127685B (de) | 1973-07-30 |
| DE1798170B1 (de) | 1972-04-27 |
| NL6812559A (de) | 1969-03-10 |
| AT288593B (de) | 1971-03-10 |
| SE341239B (de) | 1971-12-20 |
| BE720341A (de) | 1969-02-17 |
| ES357863A1 (es) | 1970-04-01 |
| GB1248764A (en) | 1971-10-06 |
| NL162209B (nl) | 1979-11-15 |
| NO138182C (no) | 1978-07-26 |
| FR1588874A (de) | 1970-03-16 |
| DK131400C (de) | 1975-11-24 |
| NL162209C (nl) | 1980-04-15 |
| FI48785C (fi) | 1974-12-10 |
| CS191857B2 (en) | 1979-07-31 |
| FI48785B (de) | 1974-09-02 |
| CH534878A (de) | 1973-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH498825A (de) | Verfahren zur Herstellung von 2-C-Methyl-nukleosiden | |
| CH526600A (de) | Verfahren zur Herstellung von Polyimiden | |
| CH513111A (de) | Verfahren zur Herstellung neuer Benz-epinderivate | |
| AT306765B (de) | Verfahren zur Herstellung von Ferrovanadin | |
| CH499489A (de) | Verfahren zur Herstellung von neuen Amino-monohalogen-phenyläthanolaminen | |
| AT293633B (de) | Verfahren zur Herstellung neuer Halogenpregnadiene | |
| AT295744B (de) | Verfahren zur Herstellung markierter Antikörper gegen Reagin-Immunoglobuline | |
| AT278846B (de) | Verfahren zur kontinuierlichen Herstellung von Isobutylidendiharnstoff | |
| CH526579A (de) | Verfahren zur Herstellung neuer Benziodoxanderivate | |
| AT292293B (de) | Verfahren zur Herstellung von Schlauchfolien | |
| AT284338B (de) | Verfahren zur Herstellung von Rifamycinen | |
| AT277964B (de) | Verfahren zur Herstellung von neuen Ketonitrilen | |
| CH496731A (de) | Verfahren zur Herstellung von Penicillinen | |
| CH492725A (de) | Verfahren zur Herstellung neuer Chinazolinonderivate | |
| AT308380B (de) | Verfahren zur Herstellung von Bauformkörpern | |
| CH482211A (de) | Verfahren zur Herstellung von Hologrammen | |
| CH517736A (de) | Verfahren zur Herstellung neuer Spiro-azatetramethylen-Derivate | |
| AT287193B (de) | Verfahren zur Herstellung von neuen Penicillinen | |
| CH485002A (de) | Verfahren zur Herstellung von Farbstoffen | |
| AT278035B (de) | Verfahren zur Herstellung von neuen Benzodioxan-N-methylcarbamaten | |
| CH487145A (de) | Verfahren zur Herstellung von neuen Butoxy-dimethylbenzamiden | |
| AT283591B (de) | Verfahren zur Herstellung von Penicillinen | |
| CH507226A (de) | Verfahren zur Herstellung von neuen 3-Oxo-steroid-oximen | |
| CH523964A (de) | Fermentatives Verfahren zur Herstellung von Ergocristin | |
| CH457117A (de) | Verfahren zur Herstellung hohlraumfreier Wickelkörper |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELA | Expired due to lapse of time |